HRV Pharma Awarded Great Place To Work® Status for 2025–2026, Underscoring Trust and Inclusivity at the Workplace

▴ HRV Pharma
HRV Pharma, India’s first virtually integrated pharma company, has been awarded the prestigious Great Place to Work® Certification for the period of December 2025 to December 2026, recognising the company’s commitment to fostering an inclusive, transparent, and people-centric workplace culture.
Hyderabad, December 2025: HRV Pharma, India’s first virtually integrated pharma company, has been awarded the prestigious Great Place to Work® Certification for the period of December 2025 to December 2026, recognising the company’s commitment to fostering an inclusive, transparent, and people-centric workplace culture.
The certification reflects the organisation’s continued focus on nurturing talent, strengthening leadership practices, and building a high-trust environment where employees feel valued and empowered.
Speaking about the recognition, Hari Kiran Chereddi, MD & CEO, HRV Pharma, said, “This certification reflects the spirit of our people and the culture we have built together. At HRV Pharma, we believe that when all our associates feel supported and inspired, they create meaningful impact for the organisation and the communities we serve.”
As HRV Pharma expands its global footprint across speciality and critical-care therapies, the company continues to prioritise associate well-being, learning opportunities, and a collaborative work ethos. This recognition underscores HRV Pharma’s belief that a strong, motivated workforce is central to driving innovation and delivering better healthcare outcomes.
Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Common Medical Terms Explained: A Plain-Language Guide for Indian Patients and Healthcare SeekersAugust 03, 2026
Why Radiology Is the Backbone of Modern Medical Diagnosis and TreatmentAugust 03, 2026
Pathophysiology of Psoriatic Arthritis: Clinical Presentation, Joint Damage Mitigation, and BiologicsAugust 01, 2026
Early Markers of Glaucoma: Structural vs. Functional Ophthalmic Diagnostic ProtocolsAugust 01, 2026
Managing Complex Diabetic Foot Ulcers: Multidisciplinary Wound Care, Offloading, and RevascularizationAugust 01, 2026
The Future of Preventive Medicine: How India Is Moving From Cure to PreventionAugust 01, 2026
Why Young Indians Are Facing Heart Problems: Causes, Symptoms, and PreventionAugust 01, 2026
The Future of Preventive Screening: AI-Driven Early Cancer Detection in IndiaJuly 31, 2026
The Impact of Climate Change on Allergic Respiratory Diseases in Indian Cities July 31, 2026
Electronic Medical Records: What They Are, Why They Matter, and How India Is Embracing ThemJuly 31, 2026
Heatwave Health Risks in India: Symptoms, Treatment, and Prevention StrategiesJuly 31, 2026
Rare Chest Wall Reconstruction at SRM Global Hospital Saves Critically Injured Road Accident VictimJuly 30, 2026
52-Year-Old Male with just 10% Heart Function successfully revived at Fortis Greater Noida via High-Risk Emergency AngioplastyJuly 30, 2026
Yashoda Hospitals Hitec City Achieves Landmark Milestone of 400+ Renal Transplants in less than 4 YearsJuly 30, 2026
Prostate Health Awareness: What Every Indian Man Must Know About Early Detection and PreventionJuly 30, 2026
Why Young Indians Are Facing Heart Problems: Causes, Warning Signs, and What to DoJuly 30, 2026
FemCare brand Healthfab acquires 2 acres land in Andhra Pradhesh to launch 2nd manufacturing facility for period care range of products; to invest Rs 15 crore July 29, 2026
Geriatric Wellness: New Technologies for Aging in Place GracefullyJuly 29, 2026
Digital Eye Strain 2.0: Protecting Vision in the Era of Spatial ComputingJuly 29, 2026
Endometriosis Awareness in India: Understanding the Condition That Affects Millions of Women in SilenceJuly 29, 2026